Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to learn about the gut microbiome in healthy postmenopausal women aged 50-64. The main questions it aims to answer are:
Participants will eat 2 apples a day for a period of 6 weeks.
Six weeks includes the period from the start of the study and gathering of baseline characteristics/questionnaires till the finish.
It is know that estrogen levels decrease after menopause. There are many different factors affecting these levels though; the gut microbiome has been identified as one of these. Not only the composition of the gut microbiota plays a role here, but also its activity is of special interest. The gut microbiota for instance produces the bacterial enzyme β-glucuronidase which has been shown to de-conjugate biliary excreted estrogens, leading to reactivation and reabsorption of estrogens into the bloodstream. It might be expected that this reabsorption results in elevated blood estrogen levels. Elevated levels of estrogen have been linked to not only development but also recurrence of breast cancer.
Apples are known for their pectin which has prebiotic properties and a potential decreasing effect on β-glucuronidase activity. In vitro studies and animal studies have already shown the β-glucuronidase decreasing impact of pectin. In humans this was never examined before.
This study aims to investigate whether it is possible to lower the activity of the bacterial enzyme β-glucuronidase and the abundance of β-glucuronidase-producing bacteria by a simple dietary intervention. This dietary intervention consists of the ingestion of two whole apples a day, one in the morning and one in the evening, during the period of 6 weeks. Thereby this study aims to examine the feasibility of this intervention.
It is hypothesized that
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Apple intervention | Experimental | the eating of 2 apples a day for a period of 6 weeks |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Eating apples | Other | the eating of 2 apples a day for a period of 6 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| The activity of the bacterial enzyme β-glucuronidase and the abundance of β-glucuronidase-producing bacteria | This will be measured in fecal samples by using a validated β-glucuronidase enzyme activity assay, which is based on previous studies. | 6 weeks per patient |
| Changes in gut microbiota composition, diversity, and functional capacity | Gut microbiota composition, diversity | 6 weeks per patient |
| Feasibility of eating 2 apples a day for a period of 6 weeks | feasibility | 6 weeks per patient |
| Measure | Description | Time Frame |
|---|---|---|
| Fecal levels of short-chain fatty acids (SCFA) | SCFA | 6 weeks per patient |
| Dietary intake, medication, stool classification and frequency, blood pressure, weight, length and quality of life before and after the intervention |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Marjolein Smidt, prof. dr. | Contact | 043 - 3877477 | m.smidt@mumc.nl |
| Name | Affiliation | Role |
|---|---|---|
| Marjolein Smidt, prof. dr. | Maastricht University Medical Center | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D003141 | Communicable Diseases |
| ID | Term |
|---|---|
| D007239 | Infections |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
diet/medication etc
| 6 weeks per patient |